We'll know more about the company's medium-term prospects by the end of the year.

Arrowhead Pharmaceuticals stock could build on its rally in the third quarter, Morgan Stanley says.

On February 16, Franklin Equity said the biotechnology industry has entered 2026 on a firmer footing following an extended ...

View Oncolytics Biotech Inc. ONCY stock quote prices, financial information, real-time forecasts, and company news from CNN.

TheFly reported on April 16 that Guggenheim Securities increased its price target on INSM from $227 to $230 while maintaining ...

Century Therapeutics (IPSC) analysis: autoimmune CAR-cell pivot, CNTY-813 Type 1 diabetes upside, cash burn cuts, rNPV fair ...

Legend Biotech Corporation looks like a J&J acquisition target as Carvykti sales surge and Phase 2 data impress. Click for ...

In 2025, biotechnology stocks had their best year since the COVID-19 pandemic, with the market sector’s two major indexes — the SDPR S&P Biotech ETX (NYSE: XBI) and iShares Biotech ETF (NYSE: IBB) — ...

This small company continues to kick goals. The post This ASX biotech stock could deliver 40%-plus returns Morgans says ...